Figure 10. Effect of FDX1 in high- and low-expression groups on TIDE and immunomodulatory target expression in ccRCC. (A) Expression distribution of FDX1 at different immune checkpoints in TCGA database. (B) TIDE score of FDX1 high- and low-expression group. (C) MSI score of the FDX1 high- and low-expression group. (D) Exclusion score of FDX1 high- and low-expression group. (E) Dysfunction score of FDX1 high- and low-expression group.